+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viral Inactivation - Global Strategic Business Report

  • PDF Icon

    Report

  • 173 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4806193
The global market for Viral Inactivation was estimated at US$627.6 Million in 2023 and is projected to reach US$1.4 Billion by 2030, growing at a CAGR of 11.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Viral Inactivation Kits & Reagents segment, which is expected to reach US$777.3 Million by 2030 with a CAGR of a 11.5%. The Viral Inactivation Systems segment is also set to grow at 12.2% CAGR for the next 7-year period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $190.5 Million in 2023, and China, forecasted to grow at an impressive 11.1% CAGR to reach $234.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Viral Inactivation Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Viral Inactivation Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Viral Inactivation Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Charles River Laboratories International, Inc., Clean Cells Inc., Danaher Corporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 42 Featured):

  • Charles River Laboratories International, Inc.
  • Clean Cells Inc.
  • Danaher Corporation
  • Merck KgaA
  • Parker Hannifin Corporation
  • Rad Source Technologies, Inc.
  • Sartorius AG
  • SGS Group (SGS SA)
  • Texcell, Inc.
  • V.I.P.S. SA
  • WuXi AppTec Group

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Viral Inactivation - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Viral Inactivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Viral Inactivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Viral Inactivation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Vaccines and Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Vaccines and Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Vaccines and Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Stem Cell Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Stem Cell Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Stem Cell Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Blood and Blood Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Blood and Blood Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 21: World 16-Year Perspective for Blood and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Tissue/ Tissue Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Tissue/ Tissue Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 24: World 16-Year Perspective for Tissue/ Tissue Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Cellular and Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Cellular and Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 27: World 16-Year Perspective for Cellular and Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 28: World Viral Inactivation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
JAPAN
  • Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
CHINA
  • Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 47: China Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: China 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 50: China Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: China Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: China 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
EUROPE
  • Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Viral Inactivation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Viral Inactivation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Viral Inactivation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: Europe 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
FRANCE
  • Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 62: France Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: France 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 65: France Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: France Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: France 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
GERMANY
  • Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 71: Germany Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Germany Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: Germany 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
ITALY
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 77: Italy Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Italy Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: Italy 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 80: UK Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 83: UK Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: UK Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: UK 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
REST OF EUROPE
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Rest of Europe Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: Rest of Europe 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 94: Asia-Pacific 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
REST OF WORLD
  • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Rest of World Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 100: Rest of World 16-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2014, 2024 & 2030
  • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Rest of World Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 103: Rest of World 16-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Charles River Laboratories International, Inc.
  • Clean Cells Inc.
  • Danaher Corporation
  • Merck KgaA
  • Parker Hannifin Corporation
  • Rad Source Technologies, Inc.
  • Sartorius AG
  • SGS Group (SGS SA)
  • Texcell, Inc.
  • V.I.P.S. SA
  • WuXi AppTec Group

Table Information